Enigma Biomedical Intelligence

Enigma Biomedical is a private brain health and neurodegeneration-focused company developing and commercializing imaging biomarkers, fluid biomarker services, and data tools for pharmaceutical and academic research. The company centers on molecular imaging for neurological pathologies, with programs spanning tau PET, amyloid imaging, neuroinflammation imaging, and multimodal biomarker data integration. Enigma markets its BioIntelligence capabilities through the NeuroAI Toolbox, which combines PET, MRI/CT, fluid biomarkers, and clinical data with artificial intelligence to support disease staging and therapeutic development. Its business model appears to blend licensing of imaging agents, biomarker-development partnerships, clinical research support, and analytics infrastructure for CNS drug development. Recent collaborations indicate active work with AbbVie, Neuraly, Alamar Biosciences, and academic partners in neurodegenerative disorders.